// App-Quantinova.ai

TCT-340 : Efficacy and Safety of Biodegradable Polymer Biolimus-Eluting Stents versus Durable Polymer Everolimus-Eluting Stents in Diabetic Patients - A Prospective Non-Randomized Single Center Long Term Comparison

Researchers

Presenter

  • Pierre Sprimont

Principal Investigators

  • Christophe De Meester

  • Jean Renkin

  • Olivier Gurne

  • Joelle Kefer

  • Patrick Chenu

  • Jean Louis Vanoverschelde

  • Nadia Debbas

Medical Centers

  • Cliniques Universitaires Saint-Luc, UCL, Brussels, MN, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Myocardial infarction

  • Type 1 diabetes mellitus

  • Venous thrombosis

  • Diabetes

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved